Cargando…

NAT2 Genotype and Isoniazid Medication in Children

Detalles Bibliográficos
Autores principales: Golka, Klaus, Selinski, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049983/
https://www.ncbi.nlm.nih.gov/pubmed/27591833
http://dx.doi.org/10.1016/j.ebiom.2016.08.040
_version_ 1782457818319683584
author Golka, Klaus
Selinski, Silvia
author_facet Golka, Klaus
Selinski, Silvia
author_sort Golka, Klaus
collection PubMed
description
format Online
Article
Text
id pubmed-5049983
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-50499832016-10-07 NAT2 Genotype and Isoniazid Medication in Children Golka, Klaus Selinski, Silvia EBioMedicine Commentary Elsevier 2016-08-26 /pmc/articles/PMC5049983/ /pubmed/27591833 http://dx.doi.org/10.1016/j.ebiom.2016.08.040 Text en © 2016 Forschungsgesellschaft für Arbeitsphysiologie und Arbeitschutz e.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Golka, Klaus
Selinski, Silvia
NAT2 Genotype and Isoniazid Medication in Children
title NAT2 Genotype and Isoniazid Medication in Children
title_full NAT2 Genotype and Isoniazid Medication in Children
title_fullStr NAT2 Genotype and Isoniazid Medication in Children
title_full_unstemmed NAT2 Genotype and Isoniazid Medication in Children
title_short NAT2 Genotype and Isoniazid Medication in Children
title_sort nat2 genotype and isoniazid medication in children
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049983/
https://www.ncbi.nlm.nih.gov/pubmed/27591833
http://dx.doi.org/10.1016/j.ebiom.2016.08.040
work_keys_str_mv AT golkaklaus nat2genotypeandisoniazidmedicationinchildren
AT selinskisilvia nat2genotypeandisoniazidmedicationinchildren